Thor Medical ASA (FRA:8NN) Debt-to-Asset : 0.00 (As of Jun. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Thor Medical ASA Debt-to-Asset?

Thor Medical ASA's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was €0.04 Mil. Thor Medical ASA's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was €0.04 Mil. Thor Medical ASA's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Jun. 2024 was €28.01 Mil. Thor Medical ASA's debt to asset for the quarter that ended in Jun. 2024 was 0.00.

Thor Medical ASA Debt-to-Asset Historical Data

The historical data trend for Thor Medical ASA's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thor Medical ASA Debt-to-Asset Chart

Thor Medical ASA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Asset

Get a 7-Day Free Trial

0.04

0.02

Thor Medical ASA Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Debt-to-Asset	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Thor Medical ASA's Debt-to-Asset

For the Biotechnology subindustry, Thor Medical ASA's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Thor Medical ASA's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Thor Medical ASA's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Thor Medical ASA's Debt-to-Asset falls into.

Thor Medical ASA Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Thor Medical ASA's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0	+	0)	/	28.758
	=	0.00

Thor Medical ASA's Debt-to-Asset for the quarter that ended in Jun. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0.035	+	0.044)	/	28.013
	=	0.00

Thor Medical ASA (FRA:8NN) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Thor Medical ASA Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Thor Medical ASA's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Thor Medical ASA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Thor Medical ASA (FRA:8NN) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

TRMED:Norway 0R6Y:UK

Address

Karenslyst Alle 9C, Oslo, NOR, 0278

Website

https://www.thormedical.no

Thor Medical ASA is a company engaged in producing and supplying of alpha-particle emitters for cancer therapy. The production process is based on separation of natural occurring radioactive decay products from thorium (Th-232). The objective of the company is to supply alpha emitters to suppliers and developers of innovative drugs targeting indications of high unmet medical need, including any medical products and equipment, and to run business related thereto or associated therewith.

Thor Medical ASA Headlines

No Headlines